Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.

about

Treating the dysfunctional placenta.Comments on: Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.

P2860

Q33917113-27ADB73A-9405-482D-A846-B8EC1A683DF8 Q50054878-E0C769A6-B8FB-45F4-8EF3-95F9E2A51016

P2860

Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.

Item

http://www.wikidata.org/entity/Q53734639

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Utero-placental perfusion Dopp ...... effect of sildenafil citrate.

@en

Utero-placental perfusion Dopp ...... effect of sildenafil citrate.

@nl

type

Item

label

Utero-placental perfusion Dopp ...... effect of sildenafil citrate.

@en

Utero-placental perfusion Dopp ...... effect of sildenafil citrate.

@nl

prefLabel

Utero-placental perfusion Dopp ...... effect of sildenafil citrate.

@en

Utero-placental perfusion Dopp ...... effect of sildenafil citrate.

@nl

P1476

Utero-placental perfusion Dopp ...... effect of sildenafil citrate.

@en

P2093

Asmaa Mohamed Khidre

http://www.w3.org/2001/XMLSchema#string

Mohamed Adel El-Sayed

http://www.w3.org/2001/XMLSchema#string

Mohammad Ahmed Maher

http://www.w3.org/2001/XMLSchema#string

Said Abdel-Aty Saleh

http://www.w3.org/2001/XMLSchema#string

P2860

Blood flow velocity waveforms of the fetal middle cerebral artery in a normal population: reference values from 18 weeks to 42 weeks of gestation.

Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.

Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype.

Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes.

A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia.

Sildenafil citrate therapy for severe early-onset intrauterine growth restriction.

Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation.

Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development.

Effects of combined use of sildenafil citrate (Viagra) and 17beta-estradiol on ovine coronary and uterine hemodynamics.

Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction.

P304

1045-1050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14767058.2017.1306509

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28345432

http://www.w3.org/2001/XMLSchema#string

Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.

about

P2860

P2860

Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698